Tenax Therapeutics (TENX) Net Equity Issued and Repurchased (2010 - 2021)
Tenax Therapeutics (TENX) posted quarterly Net Equity Issued and Repurchased of $9.2 million for Q3 2021, up 40.71% year-over-year from $6.5 million in Q3 2020, and up 241502.94% on a QoQ basis from -$3808.0 in Q4 2020.
Tenax Therapeutics (TENX) Net Equity Issued and Repurchased (2010 - 2021) Analysis & Trends
Tenax Therapeutics has reported Net Equity Issued and Repurchased for 7 years, with the latest figure at $9.2 million in Q3 2021.
- Net Equity Issued and Repurchased for Q3 2021 came in at $9.2 million, up 40.71% year-over-year; the trailing twelve-month figure through Dec 2021 was $9.2 million (up 6.16% YoY), and the FY2021 annual result was $9.2 million, up 6.16% from the prior year.
- Net Equity Issued and Repurchased improved to $9.2 million in Q3 2021, from -$3808.0 in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $9.2 million in Q3 2021 and troughed at -$3808.0 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 9.19 Mn |
| Sep 30, 2021 | 9.19 Mn |
| Dec 31, 2020 | -3,808.00 |
| Dec 31, 2020 | -3,808.00 |
| Sep 30, 2020 | 6.53 Mn |
| Sep 30, 2020 | 6.53 Mn |
| Mar 31, 2020 | 2.13 Mn |
| Mar 31, 2020 | 2.13 Mn |
| Jul 31, 2014 | 543,998.00 |
| Jul 31, 2014 | 543,998.00 |
| Apr 30, 2014 | 55.04 Mn |
| Apr 30, 2014 | 55.04 Mn |
| Jan 31, 2014 | 6.44 Mn |
| Jan 31, 2014 | 6.44 Mn |
| Oct 31, 2013 | 567,000.00 |
| Oct 31, 2013 | 567,000.00 |
| Apr 30, 2013 | 4.35 Mn |
| Apr 30, 2013 | 4.35 Mn |
| Oct 31, 2012 | -2.50 Mn |
| Oct 31, 2012 | -2.50 Mn |